Castle Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $103,546 | $83,679 | $87,010 | $83,043 |
Gross Profit | 79,846 | 63,146 | 68,695 | 64,339 |
EBITDA | 2,573 | -10,350 | 1,087 | 3,454 |
EBIT | -1,497 | -14,279 | -2,690 | -362 |
Net Income | -2,060 | -14,522 | -2,332 | -501 |
Net Change In Cash | 103,546 | 83,679 | 87,010 | 83,043 |
Free Cash Flow | 6,551 | -34,584 | 19,747 | 7,797 |
Cash | 62,116 | 63,764 | 116,729 | 85,556 |
Basic Shares | 30,399 | 29,889 | 29,333 | 29,073 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $344,229 | $332,069 | $219,788 | $137,039 |
Gross Profit | 273,201 | 271,864 | 174,806 | 105,030 |
EBITDA | 11,343 | 38,138 | -45,024 | -58,344 |
EBIT | -29,428 | 22,141 | -57,354 | -68,887 |
Net Income | -24,158 | 18,245 | -57,466 | -67,138 |
Net Change In Cash | 344,229 | 332,069 | 219,788 | 137,039 |
Free Cash Flow | 28,326 | 36,540 | -19,247 | -47,287 |
Cash | 116,729 | 119,709 | 98,841 | 122,948 |
Basic Shares | 28,986 | 29,255 | 26,802 | 26,054 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.49 |
2025-12-31 | -$0.08 |
2025-09-30 | -$0.02 |